 | • レポートコード：GIR-2104Z00951 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗体薬物複合体のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗体薬物複合体の種類別市場規模（アドセトリス、カドサイラ、その他）、用途別市場規模（病院、製薬企業、研究機関）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗体薬物複合体の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Seattle Genetics/Takeda、Roche、ImmunoGen、Immunomedics、Pfizer、Celldex Therapeutics、Millennium Pharmaceuticals、Bayer HealthCare、Mersana Therapeutics、Heidelberg Pharma、Oxford BioTherapeutics、Takeda Pharmaceutical Company Limited ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アドセトリス、カドサイラ、その他 ・用途別分析2016年-2026年：病院、製薬企業、研究機関 ・抗体薬物複合体の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗体薬物複合体のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗体薬物複合体のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗体薬物複合体の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗体薬物複合体の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Antibody Drug Conjugate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Antibody Drug Conjugate size is estimated to be xx million in 2020 from USD 1746 million in 2019, with a change of XX% between 2019 and 2020. The global Antibody Drug Conjugate market size is expected to grow at a CAGR of 7.0% for the next five years.
Market segmentation
Antibody Drug Conjugate market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Adcetris
Kadcyl
Other
Market segment by Application can be divided into
Hospital
Pharmaceutical Company
Research Institutions
The key market players for global Antibody Drug Conjugate market are listed below:
Seattle Genetics/Takeda
Roche
ImmunoGen
Immunomedics
Pfizer
Celldex Therapeutics
Millennium Pharmaceuticals
Bayer HealthCare
Mersana Therapeutics
Heidelberg Pharma
Oxford BioTherapeutics
Takeda Pharmaceutical Company Limited
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Antibody Drug Conjugate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antibody Drug Conjugate Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Adcetris
1.2.3 Kadcyl
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Antibody Drug Conjugate Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmaceutical Company
1.3.4 Research Institutions
1.4 Global Antibody Drug Conjugate Market Size & Forecast
1.4.1 Global Antibody Drug Conjugate Sales in Value (2016-2026))
1.4.2 Global Antibody Drug Conjugate Sales in Volume (2016-2026)
1.4.3 Global Antibody Drug Conjugate Price by Type (2016-2026) & (USD/Unit)
1.5 Global Antibody Drug Conjugate Production Capacity Analysis
1.5.1 Global Antibody Drug Conjugate Total Production Capacity (2016-2026)
1.5.2 Global Antibody Drug Conjugate Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antibody Drug Conjugate Market Drivers
1.6.2 Antibody Drug Conjugate Market Restraints
1.6.3 Antibody Drug Conjugate Trends Analysis
2 Manufacturers Profiles
2.1 Seattle Genetics/Takeda
2.1.1 Seattle Genetics/Takeda Details
2.1.2 Seattle Genetics/Takeda Major Business
2.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Product and Services
2.1.4 Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Antibody Drug Conjugate Product and Services
2.2.4 Roche Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 ImmunoGen
2.3.1 ImmunoGen Details
2.3.2 ImmunoGen Major Business
2.3.3 ImmunoGen Antibody Drug Conjugate Product and Services
2.3.4 ImmunoGen Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Immunomedics
2.4.1 Immunomedics Details
2.4.2 Immunomedics Major Business
2.4.3 Immunomedics Antibody Drug Conjugate Product and Services
2.4.4 Immunomedics Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Antibody Drug Conjugate Product and Services
2.5.4 Pfizer Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Celldex Therapeutics
2.6.1 Celldex Therapeutics Details
2.6.2 Celldex Therapeutics Major Business
2.6.3 Celldex Therapeutics Antibody Drug Conjugate Product and Services
2.6.4 Celldex Therapeutics Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Millennium Pharmaceuticals
2.7.1 Millennium Pharmaceuticals Details
2.7.2 Millennium Pharmaceuticals Major Business
2.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Product and Services
2.7.4 Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Bayer HealthCare
2.8.1 Bayer HealthCare Details
2.8.2 Bayer HealthCare Major Business
2.8.3 Bayer HealthCare Antibody Drug Conjugate Product and Services
2.8.4 Bayer HealthCare Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Mersana Therapeutics
2.9.1 Mersana Therapeutics Details
2.9.2 Mersana Therapeutics Major Business
2.9.3 Mersana Therapeutics Antibody Drug Conjugate Product and Services
2.9.4 Mersana Therapeutics Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Heidelberg Pharma
2.10.1 Heidelberg Pharma Details
2.10.2 Heidelberg Pharma Major Business
2.10.3 Heidelberg Pharma Antibody Drug Conjugate Product and Services
2.10.4 Heidelberg Pharma Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Oxford BioTherapeutics
2.11.1 Oxford BioTherapeutics Details
2.11.2 Oxford BioTherapeutics Major Business
2.11.3 Oxford BioTherapeutics Antibody Drug Conjugate Product and Services
2.11.4 Oxford BioTherapeutics Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Takeda Pharmaceutical Company Limited
2.12.1 Takeda Pharmaceutical Company Limited Details
2.12.2 Takeda Pharmaceutical Company Limited Major Business
2.12.3 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product and Services
2.12.4 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Antibody Drug Conjugate Sales by Manufacturer
3.1 Global Antibody Drug Conjugate Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Antibody Drug Conjugate Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Antibody Drug Conjugate
3.4 Market Concentration Rate
3.4.1 Top 3 Antibody Drug Conjugate Manufacturer Market Share
3.4.2 Top 6 Antibody Drug Conjugate Manufacturer Market Share
3.5 Global Antibody Drug Conjugate Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Antibody Drug Conjugate Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antibody Drug Conjugate Market Size by Region
4.1.1 Global Antibody Drug Conjugate Sales in Volume by Region (2016-2026)
4.1.2 Global Antibody Drug Conjugate Revenue by Region (2016-2026)
4.2 North America Antibody Drug Conjugate Revenue (2016-2026)
4.3 Europe Antibody Drug Conjugate Revenue (2016-2026)
4.4 Asia-Pacific Antibody Drug Conjugate Revenue (2016-2026)
4.5 South America Antibody Drug Conjugate Revenue (2016-2026)
4.6 Middle East and Africa Antibody Drug Conjugate Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Antibody Drug Conjugate Sales in Volume by Type (2016-2026)
5.2 Global Antibody Drug Conjugate Revenue by Type (2016-2026)
5.3 Global Antibody Drug Conjugate Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Antibody Drug Conjugate Sales in Volume by Application (2016-2026)
6.2 Global Antibody Drug Conjugate Revenue by Application (2016-2026)
6.3 Global Antibody Drug Conjugate Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Antibody Drug Conjugate Sales by Type (2016-2026)
7.2 North America Antibody Drug Conjugate Sales by Application (2016-2026)
7.3 North America Antibody Drug Conjugate Market Size by Country
7.3.1 North America Antibody Drug Conjugate Sales in Volume by Country (2016-2026)
7.3.2 North America Antibody Drug Conjugate Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Antibody Drug Conjugate Sales by Type (2016-2026)
8.2 Europe Antibody Drug Conjugate Sales by Application (2016-2026)
8.3 Europe Antibody Drug Conjugate Market Size by Country
8.3.1 Europe Antibody Drug Conjugate Sales in Volume by Country (2016-2026)
8.3.2 Europe Antibody Drug Conjugate Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Antibody Drug Conjugate Sales by Type (2016-2026)
9.2 Asia-Pacific Antibody Drug Conjugate Sales by Application (2016-2026)
9.3 Asia-Pacific Antibody Drug Conjugate Market Size by Region
9.3.1 Asia-Pacific Antibody Drug Conjugate Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Antibody Drug Conjugate Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Antibody Drug Conjugate Sales by Type (2016-2026)
10.2 South America Antibody Drug Conjugate Sales by Application (2016-2026)
10.3 South America Antibody Drug Conjugate Market Size by Country
10.3.1 South America Antibody Drug Conjugate Sales in Volume by Country (2016-2026)
10.3.2 South America Antibody Drug Conjugate Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antibody Drug Conjugate Sales by Type (2016-2026)
11.2 Middle East & Africa Antibody Drug Conjugate Sales by Application (2016-2026)
11.3 Middle East & Africa Antibody Drug Conjugate Market Size by Country
11.3.1 Middle East & Africa Antibody Drug Conjugate Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Antibody Drug Conjugate Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Antibody Drug Conjugate Typical Distributors
12.3 Antibody Drug Conjugate Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Antibody Drug Conjugate Revenue by Type, (USD Million), 2021-2026
Table 2. Global Antibody Drug Conjugate Revenue by Application, (USD Million), 2021-2026
Table 3. Seattle Genetics/Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Seattle Genetics/Takeda Major Business
Table 5. Seattle Genetics/Takeda Antibody Drug Conjugate Product and Services
Table 6. Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Major Business
Table 9. Roche Antibody Drug Conjugate Product and Services
Table 10. Roche Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. ImmunoGen Basic Information, Manufacturing Base and Competitors
Table 12. ImmunoGen Major Business
Table 13. ImmunoGen Antibody Drug Conjugate Product and Services
Table 14. ImmunoGen Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Immunomedics Basic Information, Manufacturing Base and Competitors
Table 16. Immunomedics Major Business
Table 17. Immunomedics Antibody Drug Conjugate Product and Services
Table 18. Immunomedics Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Antibody Drug Conjugate Product and Services
Table 22. Pfizer Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Celldex Therapeutics Major Business
Table 25. Celldex Therapeutics Antibody Drug Conjugate Product and Services
Table 26. Celldex Therapeutics Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Millennium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Millennium Pharmaceuticals Major Business
Table 29. Millennium Pharmaceuticals Antibody Drug Conjugate Product and Services
Table 30. Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Bayer HealthCare Basic Information, Manufacturing Base and Competitors
Table 32. Bayer HealthCare Major Business
Table 33. Bayer HealthCare Antibody Drug Conjugate Product and Services
Table 34. Bayer HealthCare Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Mersana Therapeutics Basic Information, Manufacturing Base and Competitors
Table 36. Mersana Therapeutics Major Business
Table 37. Mersana Therapeutics Antibody Drug Conjugate Product and Services
Table 38. Mersana Therapeutics Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Heidelberg Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Heidelberg Pharma Major Business
Table 41. Heidelberg Pharma Antibody Drug Conjugate Product and Services
Table 42. Heidelberg Pharma Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Oxford BioTherapeutics Basic Information, Manufacturing Base and Competitors
Table 44. Oxford BioTherapeutics Major Business
Table 45. Oxford BioTherapeutics Antibody Drug Conjugate Product and Services
Table 46. Oxford BioTherapeutics Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 48. Takeda Pharmaceutical Company Limited Major Business
Table 49. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product and Services
Table 50. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Antibody Drug Conjugate Sales by Manufacturer (2019-2021e) & (K Units)
Table 52. Global Antibody Drug Conjugate Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Antibody Drug Conjugate, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Antibody Drug Conjugate Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Antibody Drug Conjugate Production Site of Key Manufacturer
Table 56. Global Antibody Drug Conjugate Sales by Region (2016-2021e) & (K Units)
Table 57. Global Antibody Drug Conjugate Sales by Region (2021-2026) & (K Units)
Table 58. Global Antibody Drug Conjugate Revenue by Region (2016-2021e) & (USD Million)
Table 59. Global Antibody Drug Conjugate Revenue by Region (2021-2026) & (USD Million)
Table 60. Global Antibody Drug Conjugate Sales by Type (2016-2021e) & (K Units)
Table 61. Global Antibody Drug Conjugate Sales by Type (2021-2026) & (K Units)
Table 62. Global Antibody Drug Conjugate Revenue by Type (2016-2021e) & (USD Million)
Table 63. Global Antibody Drug Conjugate Revenue by Type (2021-2026) & (USD Million)
Table 64. Global Antibody Drug Conjugate Price by Type (2016-2021e) & (USD/Unit)
Table 65. Global Antibody Drug Conjugate Price by Type (2021-2026) & (USD/Unit)
Table 66. Global Antibody Drug Conjugate Sales by Application (2016-2021e) & (K Units)
Table 67. Global Antibody Drug Conjugate Sales by Application (2021-2026) & (K Units)
Table 68. Global Antibody Drug Conjugate Revenue by Application (2016-2021e) & (USD Million)
Table 69. Global Antibody Drug Conjugate Revenue by Application (2021-2026) & (USD Million)
Table 70. Global Antibody Drug Conjugate Price by Application (2016-2021e) & (USD/Unit)
Table 71. Global Antibody Drug Conjugate Price by Application (2021-2026) & (USD/Unit)
Table 72. North America Antibody Drug Conjugate Sales by Country (2016-2021e) & (K Units)
Table 73. North America Antibody Drug Conjugate Sales by Country (2021-2026) & (K Units)
Table 74. North America Antibody Drug Conjugate Revenue by Country (2016-2021e) & (USD Million)
Table 75. North America Antibody Drug Conjugate Revenue by Country (2021-2026) & (USD Million)
Table 76. North America Antibody Drug Conjugate Sales by Type (2016-2021e) & (K Units)
Table 77. North America Antibody Drug Conjugate Sales by Type (2021-2026) & (K Units)
Table 78. North America Antibody Drug Conjugate Sales by Application (2016-2021e) & (K Units)
Table 79. North America Antibody Drug Conjugate Sales by Application (2021-2026) & (K Units)
Table 80. Europe Antibody Drug Conjugate Sales by Country (2016-2021e) & (K Units)
Table 81. Europe Antibody Drug Conjugate Sales by Country (2021-2026) & (K Units)
Table 82. Europe Antibody Drug Conjugate Revenue by Country (2016-2021e) & (USD Million)
Table 83. Europe Antibody Drug Conjugate Revenue by Country (2021-2026) & (USD Million)
Table 84. Europe Antibody Drug Conjugate Sales by Type (2016-2021e) & (K Units)
Table 85. Europe Antibody Drug Conjugate Sales by Type (2021-2026) & (K Units)
Table 86. Europe Antibody Drug Conjugate Sales by Application (2016-2021e) & (K Units)
Table 87. Europe Antibody Drug Conjugate Sales by Application (2021-2026) & (K Units)
Table 88. Asia-Pacific Antibody Drug Conjugate Sales by Region (2016-2021e) & (K Units)
Table 89. Asia-Pacific Antibody Drug Conjugate Sales by Region (2021-2026) & (K Units)
Table 90. Asia-Pacific Antibody Drug Conjugate Revenue by Region (2016-2021e) & (USD Million)
Table 91. Asia-Pacific Antibody Drug Conjugate Revenue by Region (2021-2026) & (USD Million)
Table 92. Asia-Pacific Antibody Drug Conjugate Sales by Type (2016-2021e) & (K Units)
Table 93. Asia-Pacific Antibody Drug Conjugate Sales by Type (2021-2026) & (K Units)
Table 94. Asia-Pacific Antibody Drug Conjugate Sales by Application (2016-2021e) & (K Units)
Table 95. Asia-Pacific Antibody Drug Conjugate Sales by Application (2021-2026) & (K Units)
Table 96. South America Antibody Drug Conjugate Sales by Country (2016-2021e) & (K Units)
Table 97. South America Antibody Drug Conjugate Sales by Country (2021-2026) & (K Units)
Table 98. South America Antibody Drug Conjugate Revenue by Country (2016-2021e) & (USD Million)
Table 99. South America Antibody Drug Conjugate Revenue by Country (2021-2026) & (USD Million)
Table 100. South America Antibody Drug Conjugate Sales by Type (2016-2021e) & (K Units)
Table 101. South America Antibody Drug Conjugate Sales by Type (2021-2026) & (K Units)
Table 102. South America Antibody Drug Conjugate Sales by Application (2016-2021e) & (K Units)
Table 103. South America Antibody Drug Conjugate Sales by Application (2021-2026) & (K Units)
Table 104. Middle East & Africa Antibody Drug Conjugate Sales by Country (2016-2021e) & (K Units)
Table 105. Middle East & Africa Antibody Drug Conjugate Sales by Country (2021-2026) & (K Units)
Table 106. Middle East & Africa Antibody Drug Conjugate Revenue by Country (2016-2021e) & (USD Million)
Table 107. Middle East & Africa Antibody Drug Conjugate Revenue by Country (2021-2026) & (USD Million)
Table 108. Middle East & Africa Antibody Drug Conjugate Sales by Type (2016-2021e) & (K Units)
Table 109. Middle East & Africa Antibody Drug Conjugate Sales by Type (2021-2026) & (K Units)
Table 110. Middle East & Africa Antibody Drug Conjugate Sales by Application (2016-2021e) & (K Units)
Table 111. Middle East & Africa Antibody Drug Conjugate Sales by Application (2021-2026) & (K Units)
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Antibody Drug Conjugate Typical Distributors
Table 115. Antibody Drug Conjugate Typical Customers
List of Figures
Figure 1. Antibody Drug Conjugate Picture
Figure 2. Global Antibody Drug Conjugate Sales Market Share by Type in 2020
Figure 3. Adcetris
Figure 4. Kadcyl
Figure 5. Other
Figure 6. Global Antibody Drug Conjugate Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Pharmaceutical Company
Figure 9. Research Institutions
Figure 10. Global Antibody Drug Conjugate Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Antibody Drug Conjugate Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Antibody Drug Conjugate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Antibody Drug Conjugate Sales (2016-2026) & (K Units)
Figure 32. Global Antibody Drug Conjugate Production Capacity (2016-2026) & (K Units)
Figure 33. Global Antibody Drug Conjugate Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Antibody Drug Conjugate Market Drivers
Figure 35. Antibody Drug Conjugate Market Restraints
Figure 36. Antibody Drug Conjugate Market Trends
Figure 37. Global Antibody Drug Conjugate Sales Market Share by Manufacturer in 2020
Figure 38. Global Antibody Drug Conjugate Revenue Market Share by Manufacturer in 2020
Figure 39. Antibody Drug Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Antibody Drug Conjugate Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Antibody Drug Conjugate Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Antibody Drug Conjugate Sales Market Share by Region (2016-2026)
Figure 43. Global Antibody Drug Conjugate Revenue Market Share by Region (2016-2026)
Figure 44. North America Antibody Drug Conjugate Revenue (2016-2026) & (USD Million)
Figure 45. Europe Antibody Drug Conjugate Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Antibody Drug Conjugate Revenue (2016-2026) & (USD Million)
Figure 47. South America Antibody Drug Conjugate Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Antibody Drug Conjugate Revenue (2016-2026) & (USD Million)
Figure 49. Global Antibody Drug Conjugate Sales Market Share by Type (2016-2026)
Figure 50. Global Antibody Drug Conjugate Revenue Market Share by Type (2016-2026)
Figure 51. Global Antibody Drug Conjugate Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Antibody Drug Conjugate Sales Market Share by Application (2016-2026)
Figure 53. Global Antibody Drug Conjugate Revenue Market Share by Application (2016-2026)
Figure 54. Global Antibody Drug Conjugate Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Antibody Drug Conjugate Sales Market Share by Country (2016-2026)
Figure 56. North America Antibody Drug Conjugate Revenue Market Share by Country (2016-2026)
Figure 57. North America Antibody Drug Conjugate Sales Market Share by Type (2016-2026)
Figure 58. North America Antibody Drug Conjugate Sales Market Share by Application (2016-2026)
Figure 59. Europe Antibody Drug Conjugate Sales Market Share by Country (2016-2026)
Figure 60. Europe Antibody Drug Conjugate Revenue Market Share by Country (2016-2026)
Figure 61. Europe Antibody Drug Conjugate Sales Market Share by Type (2016-2026)
Figure 62. Europe Antibody Drug Conjugate Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Antibody Drug Conjugate Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Antibody Drug Conjugate Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Antibody Drug Conjugate Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Antibody Drug Conjugate Sales Market Share by Application (2016-2026)
Figure 67. South America Antibody Drug Conjugate Sales Market Share by Country (2016-2026)
Figure 68. South America Antibody Drug Conjugate Revenue Market Share by Country (2016-2026)
Figure 69. South America Antibody Drug Conjugate Sales Market Share by Type (2016-2026)
Figure 70. South America Antibody Drug Conjugate Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Antibody Drug Conjugate Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の抗体薬物複合体（ADC）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Antibody Drug Conjugate Therapeutics Market The global Antibody Drug Conjugate Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and h…- 世界の抗体薬物複合体（ADC）薬物市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Antibody Drug Conjugate (ADC) Drug Market The global Antibody Drug Conjugate (ADC) Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …
- 世界の抗体薬物複合体（ADC）市場規模・現状・予測（2021年-2027年） Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased…
- 世界の二重特異性抗体医薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bispecific Antibody Drug Market The global Bispecific Antibody Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の二重特異性抗体医薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bispecific Antibody Drug Market The global Bispecific Antibody Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …